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Abstract
Background: Retinal degeneration is a main cause of blindness in humans. Neuroprotective
therapies may be used to rescue retinal cells and preserve vision. Hypoxic preconditioning
stabilizes the transcription factor HIF-1α in the retina and strongly protects photoreceptors in an
animal model of light-induced retinal degeneration. To address the molecular mechanisms of the
protection, we analyzed the transcriptome of the hypoxic retina using microarrays and real-time
PCR.
Results:  Hypoxic exposure induced a marked alteration in the retinal transcriptome with
significantly different expression levels of 431 genes immediately after hypoxic exposure. The
normal expression profile was restored within 16 hours of reoxygenation. Among the differentially
regulated genes, several candidates for neuroprotection were identified like metallothionein-1 and
-2, the HIF-1 target gene adrenomedullin and the gene encoding the antioxidative and
cytoprotective enzyme paraoxonase 1 which was previously not known to be a hypoxia responsive
gene in the retina. The strongly upregulated cyclin dependent kinase inhibitor p21 was excluded
from being essential for neuroprotection.
Conclusion: Our data suggest that neuroprotection after hypoxic preconditioning is the result of
the differential expression of a multitude of genes which may act in concert to protect visual cells
against a toxic insult.
Background
Retinal blinding diseases like retinitis pigmentosa (RP)
and age related macular degeneration (AMD) are charac-
terized by a progressive retinal degeneration which
involves the apoptotic loss of photoreceptor cells.
Although significant progress in the understanding of the
molecular mechanisms leading to AMD and RP has been
made in recent years, efficient treatments to successfully
prevent loss of vision are still not available.
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Neuroprotection is a strategy to preserve retinal function.
It aims at the interference with regulatory mechanisms of
cell death to protect photoreceptor cells. To successfully
target these mechanisms it is necessary to understand the
molecular signalling networks in the degenerating retina.
Since neither an extrinsic (activation of caspases via death
receptors) nor an intrinsic death pathway (release of cyto-
chrome c from mitochondria) seems to be activated dur-
ing retinal degeneration [1], mechanisms of
photoreceptor cell death are still poorly understood. Sev-
eral models of inherited [2] and induced [3] retinal degen-
eration are used to study the molecular events of
photoreceptor apoptosis. Inherited models mostly show a
slow progression of retinal degeneration resulting in con-
stant but low levels of apoptosis. Models of induced reti-
nal degeneration, like the light damage model [3], are easy
to handle and the synchronized response to the apoptotic
stimulus may raise apoptotic factors above detection
threshold allowing their detailed investigation.
Various preconditioning protocols are used as a strategy to
protect tissues from degenerative processes. Especially
ischemic and hypoxic preconditioning successfully
reduced the severity of induced or inherited degeneration
in tissues like brain [4,5] heart [6,7] and the retina [8-12].
Hypoxia describes a state of low oxygen. It appears patho-
logically during several diseases like cancer, stroke or heart
infarction [13] but also physiologically during develop-
ment in many tissues [14]. In the adult retina, increased
oxygen consumption during night time leads to border-
line hypoxic conditions [15]. To cope with the reduced
oxygen availability cells differentially regulate genes
including factors involved in an anti-apoptotic response
[16,17]. A key regulator of the tissue response to hypoxia
is the transcription factor hypoxia inducible factor 1 (HIF-
1), a heterodimeric protein consisting of the constitutively
and stably expressed hypoxia inducible factor 1β (HIF-1β)
and oxygen regulated subunit hypoxia inducible factor 1α
(HIF-1α). During hypoxia HIF-1α is stabilized, enters the
nucleus, recruits HIF-1β and regulates the expression of
target genes involved in different pathways like apoptosis,
metabolism or angiogenesis [18].
Hypoxic preconditioning was shown to stabilize HIF-1α
in the retina [9,12]. Stabilization of this transcription fac-
tor induces the expression of target genes with neuropro-
tective properties like vascular endothelial growth factor
(Vegf) and erythropoietin (Epo) suggesting a link between
HIF-1 driven gene expression and neuroprotection [9,12].
Exogenous application of Epo not only protects retinal
ganglion cells in a model of ischemia-reperfusion injury
[19] but also photoreceptors in the model of light induced
retinal degeneration [20,21]. However, protection of vis-
ual cells from light damage was weaker than after hypoxic
preconditioning suggesting that factors in addition to Epo
contribute to retinal protection by hypoxia. The identifica-
tion of these factors is essential for the development of
efficient neuroprotective strategies focused on the preven-
tion of retinal degeneration.
We used whole genome microarrays and real-time PCR to
detect expression of differentially regulated genes after
hypoxic preconditioning in adult mouse retinas. The anal-
ysis of the hypoxic transcriptome characterized the
response of the retina to low oxygen levels. Cyclin-
dependent kinase inhibitor 1a (p21) was among the most
strongly induced genes and occupied a central position in
a differentially regulated gene network affecting cellular
growth and proliferation. Using p21 gene knockout ani-
mals, we analyzed the impact of this gene on retinal neu-
roprotection in the model of light induced retinal
degeneration.
Results
Time frame of neuroprotection after hypoxic 
preconditioning
In previous experiments we observed an almost complete
protection of photoreceptors against light induced degen-
eration when exposed at 4 hours after hypoxic precondi-
tioning. Protection, however, was lost after prolonged
reoxygenation of 16 hours suggesting a rather short-lived
neuroprotective effect of hypoxic preconditioning [9]. To
analyze the time frame of hypoxia-induced neuroprotec-
tion in more detail, we allowed preconditioned mice to
reoxygenate for 4 h, 8 h, 12 h and 16 h, respectively,
before they were exposed to high levels of white light. As
expected, retinal morphology (Fig. 1A) was almost com-
pletely preserved in mice illuminated after a reoxygena-
tion period of 4 h. Only slight disturbances and
vesiculations in the rod outer segments but no apoptotic
nuclei with condensed chromatin were observed.
Exposure after 8 h of reoxygenation resulted in the appear-
ance of some apoptotic photoreceptor nuclei. 12 h of
reoxygenation further reduced the protection against light
damage as evidenced by the appearance of many nuclei
with condensed chromatin and an almost complete disin-
tegration of rod inner (RIS) and rod outer segments
(ROS). Retinas of mice illuminated 16 hours after hypoxic
preconditioning were as susceptible to light damage as
retinas of normoxic control mice (Fig. 1A).
The retinal response to hypoxic preconditioning
It is well known that hypoxia alters the gene expression
profile in a given tissue [22] in an attempt to cope with the
unfavourable condition. One of the major factors regulat-
ing this response is the transcription factor HIF-1, which
is activated in the hypoxic retina (Fig. 1B) [9]. Similarly,
the pro-survival transcription factor Stat3 [23], which has
been reported to be induced in several hypoxic tissuesBMC Genomics 2008, 9:73 http://www.biomedcentral.com/1471-2164/9/73
Page 3 of 14
(page number not for citation purposes)
[24], was phosphorylated and thus activated in the
hypoxic retina (Fig. 1B). The different levels of activation
(shown are examples of two mice) point to a certain vari-
ability in the response to hypoxia between individual
mice. Nevertheless, the activation of these transcription
factors suggests a differential regulation of a multitude of
potentially neuroprotective genes in the retina by hypoxic
preconditioning. Based on the time frame of neuroprotec-
tion (Fig. 1A), we analyzed the gene expression pattern in
the retina at 0 h, 2 h, 4 h, and at 16 h after hypoxia (see
Methods).
Hierarchical clustering of gene chip data showed strong
similarities of the three replica-chips of a respective time
point after hypoxia [see additional file 1]. Such clustering
was not observed in normoxic samples suggesting that
hypoxia induced a strong and specific response in the ret-
ina. This hypoxic response quickly vanished and at 4 h
Transient protection of retinal morphology by hypoxic preconditioning Figure 1
Transient protection of retinal morphology by hypoxic preconditioning. A) BALB/c mice were preconditioned by 
hypoxia for 6 h. After 4 h, 8 h, 12 h or 16 h of reoxygenation in darkness, mice were exposed to 5'000 lux of white light for 1 
h. Control animals were not preconditioned and were (normoxic) or were not (dark control) exposed to light. Retinal mor-
phology was analyzed 36 h after light exposure. Normoxic animals exposed to light showed a severe disruption of ROS and RIS 
with the appearance of many pycnotic photoreceptor nuclei. Mice exposed to light 4 hours after hypoxic preconditioning were 
almost completely protected and only some ROS vesiculation was observed. The protective effect of hypoxia was progres-
sively weakened with increasing reoxygenation time before illumination as indicated by an increased disruption of ROS and RIS 
and the increased appearance of pycnotic photoreceptor nuclei. 16 h after preconditioning the protection was completely lost. 
Hypoxic preconditioning per se did not affect retinal morphology or function even after prolonged survival (data not shown, 
[9]). Arrowheads: examples of pycnotic nuclei; ROS: rod outer segments; RIS: rod inner segments; ONL: outer nuclear layer, 
scale bar: 25 μm. B) Expression of transcription factors HIF-1α and phospho-STAT3 in the retina was analyzed in normoxic 
mice or immediately after hypoxic preconditioning by Western blotting. β-actin and STAT3 levels verified equal sample loading. 
Both transcription factors were induced immediately after hypoxia with some variability between individuals. Shown are results 
from two normoxic controls and from two mice preconditioned with hypoxia.BMC Genomics 2008, 9:73 http://www.biomedcentral.com/1471-2164/9/73
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after hypoxic preconditioning the retinal transcriptome
was similar to normoxic controls.
After normalization of the data by GCRMA algorithm to
minimize the theoretical appearance of false positive sig-
nals we detected 431 differentially regulated genes imme-
diately after hypoxia, 227 of which had a fold change
above 2 (0 h, Fig. 2). The number of regulated genes
decreased gradually until 16 h after hypoxia when just 3
genes showed altered expression levels (Fig. 2). The appli-
cation of our statistical filter for a maximal acceptable
FDR suggested that there are (statistically estimated) 25,
23, 6 and 1 false positive genes in the analyzed list of dif-
ferentially regulated genes at 0 h, 2 h, 4 h and 16 h, respec-
tively.
Prominently regulated genes
The genes with the strongest regulation after hypoxic
exposure are listed in Table 1 [for complete gene lists see
additional file 2]. The most significantly upregulated gene
(>118-fold) was found to be Obox6, a homeobox-contain-
ing, putative transcriptional activator of unknown func-
tion mainly expressed in oocytes [25]. The gene with the
strongest downregulation was the cold-inducible RNA
binding motif protein 3 (Rbm3) with a 19-fold reduced
expression immediately after hypoxia (Table 1).
Most interestingly, expression of several genes with a
potential capacity to protect photoreceptors against light-
induced cell death was upregulated (Table 1). To this
group belong p21 and Bcl2l10. In addition, genes belong-
ing to oxidative stress response pathways or lipid metabo-
lism like metallothioneins (Mt1 and Mt2), transthyretin
(Ttr) and paraoxonase1 (Pon1) were induced as was the
expression of adrenomedullin (Adm) which was previ-
ously shown to respond to hypoxic conditions [26] and to
have neuroprotective properties [27].
Some pro-apoptotic genes were downregulated after
hypoxic preconditioning (Table 1) like Mef2c, a transcrip-
tion factor involved in neuronal loss in Parkinson's dis-
ease [28] and in the regulation of apoptosis in
macrophages [29]. The genes belonging to the Rbm fam-
ily of genes are also of high interest since some members
of this family are known to have an impact on apoptosis
regulation [30].
Verification of Affymetrix microarray data
The expression of a total of 32 genes identified by the
microarrays was tested by realtime PCR. Differential
expression in response to hypoxia was verified for 21
(66%) genes (Fig. 3 and additional file 3). Quality control
analysis showed that the integrities of both retinal RNA
and chip surfaces were high [QC analysis, see additional
file 1] and are thus unlikely to be responsible for the
somewhat low confirmation frequency.
Since many of the genes which were not confirmed by
real-time PCR to be differentially regulated had a low
fold-change on the microarrays, we used only genes with
a minimal fold change of 2 for the investigations of func-
tionally related groups (see below). Figure 3 shows the
real-time PCR data of 4 selected genes with potential neu-
roprotective properties (p21, Pon1, Ttr, Adm). Consistent
with the microarray results, these genes were strongly
upregulated immediately after hypoxia and returned
quickly to normal expression levels during reoxygenation.
Biological functional groups and pathway analysis
The bioinformatics resource DAVID was used to study the
impact of differentially expressed genes on known biolog-
ical processes [31]. We obtained 39 functional groups for
upregulated genes and 8 groups for downregulated genes
immediately after hypoxia (H0). Significant functional
groups included 'apoptosis', 'cell cycle' or 'negative regula-
tion of transcription' (note that some genes appear in
more than one group) were found in the list of upregu-
lated genes (Table 2). Lists of all functional related groups
can be found in additional file 4. Gene signalling networks
affected by hypoxic preconditioning were identified using
Ingenuity Pathway analysis and the complete lists of regu-
lated genes (Fig 4 and see additional file 5). The centre of
the strongest affected pathway was occupied by p21, one of
the most strongly upregulated genes by hypoxia (Fig. 4).
All genes belonging to this pathway were differentially reg-
ulated. 70% of the genes were induced indicating that the
pathway was activated rather than repressed. All genes of
Number of genes differentially expressed immediately (0 h),  2 h, 4 h and 16 h after hypoxic preconditioning Figure 2
Number of genes differentially expressed immedi-
ately (0 h), 2 h, 4 h and 16 h after hypoxic precondi-
tioning. Gray bars: total number of significantly regulated 
genes. White bars: number of genes regulated at least 2-fold. 
The number of differentially regulated genes decreased rap-
idly during reoxygenation, indicating a fast return to the gene 
expression pattern of normoxic retinas.BMC Genomics 2008, 9:73 http://www.biomedcentral.com/1471-2164/9/73
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Table 1: Top 50 differentially regulated genes immediately after hypoxic preconditioning
Affymetrix ID Gene Symbol Gene Name FC pVal
UPREGULATED
1440257_at Obox6 oocyte specific homeobox 6 118.4 2.48E-07
1433837_at 8430408G22Rik RIKEN cDNA 8430408G22 gene 35.6 6.94E-05
1424638_at Cdkn1a cyclin-dependent kinase inhibitor 1A (p21) 30.5 3.00E-05
1454409_at 4833408G04Rik RIKEN cDNA 4833408G04 gene 24.0 2.07E-06
1418190_at Pon1 paraoxonase 1 22.5 1.98E-05
1422832_at Rgr retinal G protein coupled receptor 22.1 6.20E-05
1454608_x_at Ttr transthyretin 20.1 2.67E-04
1455913_x_at Ttr transthyretin 20.0 3.11E-04
1458610_at - --- 17.4 1.95E-04
1416434_at Bcl2l10 Bcl2-like 10 17.0 2.70E-05
1444487_at Lrat lecithin-retinol acyltransferase 16.2 6.54E-06
1441228_at Apold1 apolipoprotein L domain containing 1 11.7 7.21E-05
1438815_at Hist2h2aa2 histone 2, H2aa2 10.7 1.01E-04
1416077_at Adm adrenomedullin 10.6 2.48E-04
1430197_a_at Pitpnm2 phosphatidylinositol transfer protein, membrane-associated 2 10.3 5.36E-05
1428942_at Mt2 metallothionein 2 9.7 5.12E-06
1418808_at Rdh5 retinol dehydrogenase 5 9.7 9.82E-05
1427221_at MGI:2143217 X transporter protein 3 similar 1 gene 9.3 1.29E-04
1430817_at Samd7 sterile alpha motif domain containing 7 8.6 2.66E-04
1447494_at D7Bwg0826e DNA segment, Chr 7, Brigham & Women's Genetics 0826 expressed 7.2 5.77E-06
1428352_at Arrdc2 arrestin domain containing 2 7.1 6.05E-05
1446587_at - Transcribed locus 6.9 2.32E-04
1424838_at A330049M08Ri RIKEN cDNA A330049M08 gene 6.8 1.21E-04
1426117_a_at Slc19a2 solute carrier family 19 (thiamine transporter), member 2 6.8 1.80E-04
1430357_at H3f3b H3 histone, family 3B 6.3 5.84E-05
1422557_s_at Mt1 metallothionein 1 6.3 5.42E-06
1454991_at Slc7a1 solute carrier family 7 (cationic amino acid transporter, y+ system), 
member 1
6.1 1.39E-04
1429348_at Sema3c semaphorin 3C 5.9 3.55E-04
1442366_at 6820408C15Ri RIKEN cDNA 6820408C15 gene (6820408C15Rik), mRNA 5.6 6.15E-05
1441673_at C80120 expressed sequence C80120 5.3 1.39E-04
DOWNREGULATED
1429169_at Rbm3 RNA binding motif protein 3 19.41 2.54E-04
1435692_at LOC622320 similar to retinoic acid, EGF, and NGF upregulated 7.02 3.79E-05
1447363_s_at Bub1b budding uninhibited by benzimidazoles 1 homolog, beta (S. cerevisiae) 6.36 8.09E-06
1416961_at Bub1b budding uninhibited by benzimidazoles 1 homolog, beta (S. cerevisiae) 5.41 1.20E-06
1444172_at - Transcribed locus 4.72 2.64E-04
1435158_at Rbm12b RNA binding motif protein 12B 4.40 6.09E-05
1425083_at Otor otoraplin 4.03 2.21E-04
1445709_at Mdm1 transformed mouse 3T3 cell double minute 1 3.97 1.64E-04
1450953_at Wdr39A WD repeat domain 39 3.70 1.93E-04
1456723_at Prr14 Proline rich 14 3.49 2.35E-05
1456834_at Ibrdc2 IBR domain containing 2 (Ibrdc2), mRNA 3.45 1.76E-04
1442051_at His2h3cl histone 2, H3c1 3.39 2.63E-04
1437647_at Dido1 death inducer-obliterator 1 3.38 6.54E-05
1421379_at Zfp354b zinc finger protein 354B 3.28 3.41E-04
1424852_at Mef2c myocyte enhancer factor 2C 3.22 1.40E-04
1429655_at Nudcd1 Nudcd1 NudC domain containing 1 3.19 3.84E-04 3.19 3.84E-04
1442249_at - Transcribed locus 3.11 1.03E-04
1416920_at Rbm4 RNA binding motif protein 4 3.11 1.44E-04
1460107_at 1700129I04Rik RIKEN cDNA 1700129I04 gene 3.11 1.74E-04
1453010_at Iws1 IWS1 homolog (S. cerevisiae) 2.98 2.80E-04
FC: fold change; pVal: p-valueBMC Genomics 2008, 9:73 http://www.biomedcentral.com/1471-2164/9/73
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this pathway, which showed at least a two-fold differential
regulation on the chip, were tested by real-time PCR. Ten
of the 16 tested genes were confirmed to be regulated by
hypoxia (Table 3). This suggested that the p21-pathway
was indeed strongly affected by the hypoxic precondition-
ing protocol. Since it is known that p21 not only inhibits
cell cycle but can also repress apoptosis [32], it was consid-
ered as a strong candidate for the involvement in neuro-
protection by hypoxic preconditioning.
The influence of p21 on retinal neuroprotection in the 
model of light induced degeneration
The hypothesis that p21 is important for neuroprotection
in the retina after hypoxic preconditioning was directly
tested using p21 knockout animals. Both, normoxic and
hypoxic preconditioned p21-/- mice were exposed to high
intensity visible light for 2 hours and retinal morphology
was analyzed 10 days thereafter (Fig. 5). As expected, nor-
moxic control p21-/- mice showed strong damage after
light exposure with the loss of all photoreceptors in the
central retina. If p21 was involved in neuroprotection
after hypoxic exposure, preconditioned p21-/- mice should
show an increased susceptibility to light damage as com-
pared to wild type mice. However, photoreceptors of the
p21 knockout mice were completely protected after pre-
conditioning (Fig. 5). The quantification of cell death by
biochemical assays (data not shown) supported our con-
clusion that p21 does not contribute significantly to the
neuroprotective effect observed after hypoxic precondi-
tioning. Furthermore, most genes identified by Ingenuity
Pathway analysis as being part of the p21 signalling net-
work were similarly regulated in the presence or absence
of functional p21. The only exception was Semaphorin 3c
(Sema3c), which showed no hypoxic upregulation in the
absence of p21 (data not shown).
Discussion
Hypoxic preconditioning is strongly neuroprotective and
prevents photoreceptor apoptosis after exposure to high
levels of visible light [9]. The transcription factors HIF-1
and Stat3 are activated. This suggests differential regula-
tion of the expression of various target genes which was
confirmed by the detection of 431 differentially regulated
genes immediately after hypoxia. More than 50% of these
genes showed at least a 2-fold difference in the expression
level as compared to normoxic retinas. Among those were
also Rgr and Lrat, two genes highly expressed in the retinal
pigment epithelium. Genes normally not or only barely
expressed in the neuronal retina may easily reach a high-
fold induction when the tissue is contaminated with
neighbouring cells expressing the respective gene at high
levels. Low levels of oxygen during hypoxic precondition-
ing may have altered the physical interaction properties
between neuronal retina and retinal pigment epithelium
(RPE) leading to an increased contamination rate of the
retina by cells of the RPE during tissue isolation. Thus,
fold inductions have to be interpreted cautiously.
Reoxygenation caused the rapid return to a normal gene
expression pattern. This is in line with a model of hypoxic
preconditioning in brain where it was shown that differ-
ential gene regulation was low between 12 and 18 hours
of reoxygenation [33]. In models of ischemic precondi-
tioning (IPC), however, differential gene expression is
observed immediately after the stimulus until up to 7 days
after preconditioning [34-36]. This goes together with a
long lasting neuroprotective effect of IPC observed in the
retina [10] and in brain [37] suggesting that mechanisms
of IPC may differ from those of acute hypoxic precondi-
tioning. An extended neuroprotection by hypoxic precon-
ditioning may be achieved by the repetitive exposure to
low oxygen [12].
Similarities of hypoxic preconditioning and IPC
Although mechanisms of hypoxic preconditioning and
IPC may differ, few genes were found to be differentially
regulated in both types of preconditioning protocol.
Among those are metallothionein 2 (Mt2), C/ebpd (an
apoptosis-related transcription factor) and p21 [35,38].
The identification of these genes makes them strong candi-
dates for playing a role in general retinal neuroprotection.
Expression of candidate genes analyzed by real-time PCR Figure 3
Expression of candidate genes analyzed by real-time 
PCR. Expression profile of p21 (Cdkn1a), Pon1 (paraoxonase 
1) Ttr (transthyretin) and Adm (adrenomedullin) immediately 
after hypoxic exposure (0 h), or after a period of 2 h, 4 h or 
16 h of reoxygenation as determined by real-time PCR. Fold-
changes are expressed relative to normoxic controls of 
respective time points, which were set to one. n = 5 for each 
treatment and time point. White bars: samples of normoxic 
retinas, grey bars: samples of hypoxic preconditioned retinas; 
*** p ≥ 0.001, ** p ≥ 0.01, * p ≥ 0.05).BMC Genomics 2008, 9:73 http://www.biomedcentral.com/1471-2164/9/73
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An involvement of p21 was directly tested using the
respective knockout animal. As a HIF-1 target gene [39],
p21 was not only very strongly regulated but was also at
the center of a highly regulated gene network (Fig. 4).
Although p21 can be pro-apoptotic [40] and can trigger
non-apoptotic cell death [41], it is also known to have
antiapoptotic properties [42]. However, the test of p21
knockout mice in the model of light induced degenera-
tion revealed no significant impact of p21 on neuroprotec-
tion against light damage. Despite the lack of p21, all
other genes of the p21 pathway (except for Sema3c)
showed the same response to hypoxic preconditioning as
in wild type mice. This raises the possibility that other
genes of the p21 network might influence retinal neuro-
protection. Specific candidates are Timp3 which has been
reported to be a promoter of apoptosis through the inhi-
bition of metalloproteinases [43] and Egf  which has
proven anti-apoptotic properties [44].
Mt2, as a gene also detected in both preconditioning
schemes, may play an important role as a scavenger of free
radicals [45]. It is interesting to note that metal-
lothioneins are also induced after ischemic precondition-
ing of the rat spinal cord [34] and that they have been
reported to be neuro- and cardioprotective, respectively,
in various degenerative models [46,47]. In addition, met-
allothioneins have been shown to be induced in light-
damaged retinas [48] and to protect retinas from oxidative
Table 2: Differentially regulated genes with possible impact on cell survival and neuroprotection; detected and functionally clustered 
by DAVID.
Affymetrix ID Gene Symbol Gene Name FC
Up-regulated
apoptosis (p ≥ 0.032)
1424638_at Cdkn1a cyclin-dependent kinase inhibitor 1a (p21) 30.5
1416434_at Bcl2l10 Bcl2-like 10 17.0
1442025_a_at Zbtb16 zinc finger and btb domain containing 16 3.6
1454109_a_at Ptdsr phosphatidylserine receptor 2.4
1420909_at, 1451959_a_at Vegfa vascular endothelial growth factor a 2.3
1453851_a_at Gadd45g growth arrest and dna-damage-inducible 45 gamma 2.3
1452050_at Camk1d calcium/calmodulin-dependent protein kinase id 2.1
1454903_at Ngfr nerve growth factor receptor (TNFR superfamily, member 16) 2.0
cell cycle (p ≥ 0.013)
1424638_at Cdkn1a cyclin-dependent kinase inhibitor 1A (P21) 30.5
1416309_at Nusap1 nucleolar and spindle associated protein 1 4.4
1454018_at Tlk2 tousled-like kinase 2 (Arabidopsis) 4.3
1449007_at Btg3 B-cell translocation gene 3 4.2
1424143_a_at, 1424144_at Cdt1 retroviral integration site 2 3.4
1419024_at, 1455002_at Ptp4a1 protein tyrosine phosphatase 4a1 2.7
1453851_a_at Gadd45g growth arrest and DNA-damage-inducible 45 gamma 2.3
1420909_at, 1451959_a_at Vegfa vascular endothelial growth factor A 2.3
1459978_x_at - gene model 877 (NCBI) 2.0
1435870_at Sycp3 synaptonemal complex protein 3 2.0
negative regulation of transcription (p ≥ 0.031)
1442025_a_at Zbtb16 zinc finger and btb domain containing 16 3.6
1425809_at Fabp4 Fatty acid binding protein 4, adipocyte (Fabp4), mRNA 3.5
1425895_a_at Id1 inhibitor of DNA binding 1 3.1
1442397_at Nfx1 nuclear transcription factor, X-box binding 1 2.7
1425732_a_at Mxi1 Max interacting protein 1 2.1
Down-regulated
regulation of transcription (p ≥ 0.09)
1440343_at Rps6ka5 ribosomal protein S6 kinase, polypeptide 5 0.42
1450034_at Stat1 signal transducer and activator of transcription 1 0.47
1416826_a_at Trfp Trf (TATA binding protein-related factor)-proximal protein homolog (Drosophila) 0.41
1450953_at Wdr39 WD repeat domain 39 0.27
1421379_at Zfp354b zinc finger protein 354B 0.31
1424852_at Mef2c myocyte enhancer factor 2C 0.31
1437647_at Dido1 death inducer-obliterator 1 0.30
1443952_at Thra thyroid hormone receptor alpha 0.48
1428760_at Snapc3 small nuclear RNA activating complex, polypeptide 3 0.40
1456723_at Prr14 Proline rich 14 0.29
Analysis of the gene expression pattern was immediately after hypoxia; FC: fold changeBMC Genomics 2008, 9:73 http://www.biomedcentral.com/1471-2164/9/73
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The most prominently affected gene network discovered by Ingenuity Pathway Analysis Figure 4
The most prominently affected gene network discovered by Ingenuity Pathway Analysis. Network was classified 
as: Cellular growth & proliferation, DNA replication, recombination & repair. Pathway contains pro survival genes like Egf, Vegf and 
p21, which occupy central positions in this network. Red: induction; green: repression; white: unaffected; colour intensity cor-
relates with fold change.BMC Genomics 2008, 9:73 http://www.biomedcentral.com/1471-2164/9/73
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stress caused by the glutamate analogue NMDA [49]. Fur-
ther experiments are clearly needed to evaluate the impact
of this protein in retinal neuroprotection.
The low similarity of the transcriptome after IPC and
hypoxic preconditioning may be surprising but might be
based on the different nature of the preconditioning pro-
tocols. Whereas IPC normally uses a very short (minutes)
ischemic stimulus followed by reperfusion, our protocol
of hypoxic preconditioning uses exposure to 6 hours of
low oxygen concentrations followed by the immediate
analysis. The different length of exposure to low oxygen
and the interrupted supply of nutrients in one (IPC) but
not the other protocol might essentially explain the differ-
ences in the gene expression patterns.
Strong candidate genes for neuroprotection: Adm, Pon1
Adrenomedullin (Adm) is a multifunctional protein
involved in angiogenesis, cancer promotion, host defence
and neuroprotection [50]. Elevated levels of Adm were
found in plasma of patients suffering from retinitis pig-
mentosa [51]. Previous reports identified Adm as a target
gene of HIF-1α [52,53] linking it to a possible HIF – medi-
ated protection mechanism.
Interestingly, some genes which so far were not described
in the context of hypoxia, like paraoxonase 1 (Pon1), were
also highly induced. Pon1 is a high-density lipoprotein
(HDL) associated enzyme which plays a major role in the
prevention of lipid peroxidation [54,55]. Since retinal
degeneration involves oxidative stress and inhibition of
lipid peroxidation protects against light damage [56] Pon1
may have an important role in retinal protection after
hypoxic preconditioning. Recently, Pon1  levels were
found to be reduced in serum of AMD patients whereas a
marker for oxidative stress was elevated [57]. This may
suggest that elevated levels of Pon1 in our model might
reduce oxidative stress and prevent photoreceptor degen-
eration. Interestingly, C57Bl/6 mice which have a reduced
sensitivity to light damage show a higher basal expression
of Pon1 than light sensitive strains (data not shown). If the
anti-oxidative enzyme Paraoxonase 1 was involved in the
protection of the retina against oxidative damage, the dif-
ferent basal expression levels of Pon1 might contribute to
the different light damage susceptibilities of various
mouse strains.
Additional genes with potential neuroprotective function
Bcl2-like 10 (Bcl2l10) is a anti-apoptotic member of the
Bcl2 family [58] acting to suppress cell death by prevent-
ing cytochrome c release, casp-3 activation and mitochon-
drial membrane collapse [59]. However, retinal
degeneration induced by acute light exposure may not
depend on cytochrome c release or caspase activation
[60]. Therefore, upregulation of Bcl2l10 might not be
responsible for photoreceptor protection by hypoxic pre-
conditioning.
Induction of the HIF-1 target gene Vegfa is an attempt to
increase tissue oxygen levels by improving blood circula-
Table 3: Real-Time PCR results of 16 genes belonging to the p21 
pathway compared to the fold change (FC) detected by 
Affymetrix microarrays.
Gene symbol FC Affymetrix 
Chip
FC PCR
Cdkn1a (p21) 30.5 20.3*
Sema3c 5.9 3.9*
Egf 4.7 2.8*
HMGB2 4.1 3.0*
Fabp4 3.5 5.3*
CEBPd 3.5 3.5*
Timp3 3.3 3.7*
ID1 3.1 1.8*
Rad23b 2.6 1.2
Vegf 2.3 2.0*
Stom 2.0 1.3
Hes6 1.9 1.6*
SOS1 1.9 0.9
Stat1 0.5 1.1
Thra 0.5 0.8
IBRDC2 0.3 0.9
Analysis of gene expression was immediately after hypoxia
FC: fold change. * p < 0.05
Role of p21 in hypoxic preconditioning Figure 5
Role of p21 in hypoxic preconditioning. Hypoxic pre-
conditioned (hypoxia) or normoxic (normoxia) p21-/- mice 
were exposed to 13'000 lux of white light for 2 hours and 
retinal morphology was analyzed 10 days thereafter. Dark-
adapted knockout mice served as controls (dark control). 
Hypoxic preconditioning almost completely protected the 
retina of p21-/- mice leading to a retinal morphology indistin-
guishable from controls. Exposure of normoxic mice led to a 
complete degeneration of photoreceptors in the central ret-
ina. Shown are representative samples of control and light 
exposed mice. n = 2 (controls); n = 4 (light exposed mice). 
Abbreviations as in Fig. 1. Scale bar: 25 μm.BMC Genomics 2008, 9:73 http://www.biomedcentral.com/1471-2164/9/73
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tion through the formation of new vessels [61]. In the ret-
ina Vegfa is also recognized as a pro-survival factor
protecting retinal neurons against ischemic injury [62].
However, Vegfa is discussed to have also pro-apoptotic
properties [63] and its potential role in the precondition-
ing scheme is unclear. Ptdsr encodes a posphatidylserine
receptor involved in the clearance of apoptotic cells [64]
and it has been shown that lack of Ptdsr activity can
increase tissue damage through the stimulation of apop-
tosis in cells neighbouring apoptotic cells [65]. Ptdsr is
also involved in the elimination of apoptotic debris of
dying photoreceptors by macrophage-mediated phagocy-
tosis which is important for the maintenance of retinal tis-
sue integrity [66].
Downregulated genes with a possible impact on cell death
included Mef2c and genes of the Rbm family of protein.
Mef2c triggers apoptosis in macrophages [29] and may be
involved in dopaminergic neuron death in Parkinson's
disease [28]. Because macrophages seem to play an
important role in light induced apoptosis [67,68] a poten-
tial influence on neuroprotection may be possible but
needs further investigation. This is also true for the identi-
fied members of the Rbm family. Although these proteins
have been implicated in the modulation of apoptosis
[30], and downregulation of Rbm3 has been specifically
connected to the regulation of cell cycle progression [69]
and the inhibition of apoptosis [70], their role is still con-
troversial.
Conclusion
Since hypoxia can either lead to adaptation and protec-
tion [71] or to apoptosis [72] it may not be surprising that
we identified several genes which may rather be involved
in promoting apoptosis than in its inhibition. Neuropro-
tection by hypoxic preconditioning may thus depend on
a balance between numerous anti- and proapoptotic fac-
tors. The loss of individual proteins like p21 may not be
sufficient to shift the balance towards apoptosis. Likewise,
it might require several different antiapoptotic factors to
fully protect the retina. Full neuroprotection may only be
achieved by controlling the central regulators of the
hypoxic response like the transcription factors HIF and/or
STAT3.
Methods
Animals, hypoxic preconditioning and light damage
Animals were treated in accordance with the regulations
of the Veterinary Authority of Zurich and with the state-
ment of 'The Association for Research in Vision and Oph-
thalmology' for the use of animals in research. BALB/c
mice were purchased from Harlan (The Netherlands) and
p21-/-  mice on a mixed Bl/6;129S2 background were
obtained from Jackson Laboratory (Bar Harbor, USA). All
mice were homozygous for the light sensitive Rpe65450Leu
variant [73]. Hypoxic preconditioning (6% O2  for 6
hours) was performed as described previously [9]. Reoxy-
genation was allowed in darkness for 4 h, 8 h, 12 h and 16
h in normal room air. After reoxygenation BALB/c mice
were exposed to 5'000 lux of white fluorescent light for 1
h and analyzed at time points as indicated.
Pupils of p21-/- animals (pigmented) were dilated in dim
red light using 1% Cyclogyl (Alcon, Cham, Switzerland)
and 5% Phenylephrine (Ciba Vision, Niederwangen,
Switzerland) 45 minutes prior to illumination. Light dose
(13'000 lux) and exposure duration (2 h) was adjusted
according to the decreased light damage susceptibility of
this mouse strain. After light exposure animals remained
in darkness until analyzed or at the most for 36 h.
For morphology mice were sacrificed 36 h or 10 days after
light exposure and eyes were enucleated and processed as
previously described [74].
RNA isolation and Affymetrix microarrays
Retinas were isolated immediately, 2 h, 4 h and 16 h after
hypoxic preconditioning, frozen in liquid nitrogen and
stored at -70°C. Normoxic controls were treated in paral-
lel and collected at the same time points. For Affymetrix
microarrays 3 retinas of 3 different mice were pooled. This
procedure was repeated 3 times to generate independent
biological triplicates. RNA was extracted using the RNeasy
isolation kit (Qiagen, Hilden, Germany), including a
DNase treatment to digest residual genomic DNA. RNA
was processed according to standard procedures and
hybridized to Affymetrix GeneChip® Mouse Genome 430
2.0 microarrays. The 3 experimental replicates were
hybridized independently resulting in three microarray
replicates per condition. In total, 24 Affymetrix gene chips
were hybridized with RNA from 72 retinas of 72 mice.
Quality control (QC) and Affymetrix microarray analysis
To analyze the quality of the results after gene chip hybrid-
ization we employed RReporterGenerator [75] combining
Affymetrix-style QC, RMA and residual QC. The complete
report is available in additional file 1.
Affymetrix raw gene expression data were summarized
and normalized using the GCRMA procedure [76]. The
data were filtered in order to remove probe-sets with con-
stant low-level expression. Probe-sets were removed
which showed replicate means for a given time-point for
both treatments below the threshold separating the two
peaks of the bimodal distribution of signal-intensity val-
ues. This procedure was performed independently for
each of the differential testing procedures. The filtered
data-sets were subsequently subjected to t-tests with mul-
tiple testing correction and control of the false discovery
rate (FDR) using OCplus package [77] available underBMC Genomics 2008, 9:73 http://www.biomedcentral.com/1471-2164/9/73
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Bioconductor [78]. By comparing the plotted number of
differentially expressed genes at various FDR levels, corre-
sponding threshold values for the maximum acceptable
FDR were chosen with the aim of keeping homogenous
groups with similar FDR together.
To group differentially regulated genes according to their
biological function the Affymetrix IDs were imported into
the Database for Annotation, Visualization and Integrated
Discovery (DAVID) from the National Institute of Allergy
and Infectious Diseases (NIAID), NIH [31,79] and into
Ingenuity Pathway Analyses from Ingenuity Systems [80].
Real-time PCR
cDNA was prepared from equal amounts of total retinal
RNA, using oligo(dT) primers and M-MLV reverse tran-
scriptase (Promega, Madison, WI, USA). 10 ng of cDNA
was amplified in a LightCycler 480 instrument (Roche
Diagnostics AG, Rotkreuz, Switzerland) using LightCycler
480 SYBR Green I Master Mix (Roche Diagnostics AG) and
appropriate primer pairs [see additional file 6]. mRNA
levels were normalized to β-actin and relative values were
calculated using a respective calibrator.
Western blotting
Retinas were homogenized in 0.1 M Tris/HCl (pH 8.0) by
sonification at 4°C. The protein content was determined
using a Bradford assay (Bio-Rad, Munich, Germany). Pro-
tein extracts were mixed with SDS sample buffer and incu-
bated for 10 min at 90°C. Proteins were separated by SDS-
PAGE and blotted onto a nitrocellulose membrane. After
blocking with 5% non-fat dry milk (Bio-Rad, Munich,
Germany) in TBST (Tris/HCl 10 mM, pH 8; 150 mM
NaCl; 0.05% Tween-20) membranes were incubated with
primary antibodies at 4°C over night. Primary antibodies
used were: rabbit anti-HIF-1α (Novus Biologicals NB
100–479; 1:1000), rabbit anti-phospho-STAT3 (Cell Sig-
nalling; 1:500), rabbit anti-STAT3 (Cell Signalling
1:1000) and goat anti-β-actin (Santa Cruz; 1:1000). After
incubation with horseradish peroxidase labelled second-
ary antibodies for 1 h at room temperature the protein
bands were visualized by the application of a chemilumi-
nescent substrate (PerkinElmer, Boston, USA) and expo-
sure to a Super RX film (Fujifilm, Dielsdorf, Switzerland).
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